Amyotrophic lateral sclerosis (ALS) is
IN VIVO MODELS OF MOTOR NEURON DEGENERATION

Axotomy-Induced Motor Neuron Death
Given the complexities of living organisms, in vivo animal models of human disease would appear to offer the best system for testing the true efficacy of potential therapeutic interventions. Direct trauma to the motor nerve axon by peripheral nerve transection (axotomy) offers a reproducible method for inducing motor neuron degeneration. When performed in neonatal animals, axotomy results in the death of virtually all motor neurons whose axons were severed (Schmalbruch, 1984; Snider & Thanedar, 1989; see Elliott & Snider, 1996 , for a review). The time course of axotomyinduced death is acute (over several days), allowing for rapid data accumulation or experimental repetition, and occurs in a stereotypical pattern characteristic of apoptosis (Gerfen et al., 1995; Deckwirth et al., 1996) . Because many of the molecular determinants of apoptosis are known, neuronal death following axotomy is becoming increasingly well understood and approachable to manipulation either by genetic or pharmacologic methods.
Although axotomy-induced motor neuron degeneration is an invaluable system for studying apoptosis, its relevance to human ALS is less certain. Axotomyinduced injury represents an acute massive one-time event and may set in motion a cascade of events that is different from more chronic or continuous insults. Furthermore, ALS is a disease that is clinically manifest in adult neurons, while axotomy-induced death is primarily a phenomenon of immature motor neurons,
